Quantcast

Latest Dana-Farber Cancer Institute Stories

2014-05-28 08:32:11

National Nonprofit Organization Contributes $1.2 Million to Support Pediatric Cancer Research Projects Nationwide ATLANTA, May 28, 2014 /PRNewswire-USNewswire/ -- Rally Foundation for Childhood Cancer Research (Rally), a national nonprofit organization, today announced that it is awarding more than $1.2 million to 30 hospitals across the country as part of its annual funding allocation for 2014. "Rally enables cutting-edge research to continue what would otherwise not be possible...

2014-04-25 08:27:52

NEW YORK, April 25, 2014 /PRNewswire/ -- Uniting Against Lung Cancer (UALC), a nonprofit dedicated to funding innovative research and raising awareness for lung cancer, announces that it has achieved a new level of funding this year, committing more than $1.5 million in lung cancer research grants to premier medical and research institutions across the country. This contribution brings UALC's total funding for lung cancer research grants to a total of $11.5 million. Lung cancer is...

2014-04-24 10:48:03

The humble aspirin may have just added another beneficial effect beyond its ability to ameliorate headaches and reduce the risk of heart attacks: lowering colon cancer risk among people with high levels of a specific type of gene. The extraordinary finding comes from a multi-institutional team that analyzed data and other material from two long-term studies involving nearly 128,000 participants. The researchers found that individuals whose colons have high levels of a specific gene product...

2014-04-21 13:46:28

Although doctors have long known that people with Down syndrome have a heightened risk of developing acute lymphoblastic leukemia (ALL) during childhood, they haven't been able to explain why. Now, a team of Dana-Farber Cancer Institute investigators has uncovered a connection between the two conditions. In a study posted online today by the journal Nature Genetics, the researchers track the genetic chain of events that links a chromosomal abnormality in Down syndrome to the cellular havoc...

2014-04-18 12:35:28

A Dana-Farber/Boston Children's and VA Hospital/University of South Florida team created the antiviral therapy, which harnesses the power of stapled peptide and nanoparticle technologies to thwart the respiratory virus New therapies are needed to prevent and treat respiratory syncytial virus (RSV) – a potentially lethal respiratory infection that can severely affect infants, young children and the elderly. Despite a wide range of anti-RSV efforts, there are no vaccines or drugs on the...

2014-04-07 16:05:15

Researchers studying a rare, always fatal brain tumor in children have found several molecular alterations that drive the cancer, according to a new study from scientists at Dana-Farber/Boston Children's Cancer and Blood Disorders Center and McGill University. The findings identify potential new targets for drug treatments. The new research could help physicians choose targeted agents with a better chance of combating pediatric high-grade astrocytomas, which are extremely difficult to...

2014-03-26 12:29:02

Comprehensive BMT(TM) will deliver an unmatched hematopoietic stem cell transplant (HSCT) data management solution for improved research and reporting SALT LAKE CITY, March 26, 2014 /PRNewswire/ -- Remedy Informatics, Inc., the leading provider of registry-based clinical informatics software for healthcare delivery and life sciences research, announced that it has been selected by the Stem Cell Transplantation program at Dana-Farber/Brigham and Women's Cancer Center to implement Comprehensive...

2014-02-04 11:57:02

Largest-ever study of 20-year survival among pediatric low-grade glioma patients highlights radiation's association with higher mortality The first comprehensive, large-scale cohort study of the long-term survival of children treated for low-grade gliomas, the most common pediatric brain tumor, finds that almost 90 percent are alive 20 years later and that few die from the tumor as adults. However, children who received radiation as part of their treatment had significantly lower long-term...

2014-01-24 13:27:45

Dana-Farber Cancer Institute scientists have developed a mathematical model to predict how a patient's tumor is likely to behave and which of several possible treatments is most likely to be effective. Reporting in the journal Cell Reports, researchers combined several types of data from pre- and post-treatment biopsies of breast tumors to obtain a molecular picture of how the cancer evolved as a result of chemotherapy. "Better understanding of tumor evolution is key to improving the...

2013-12-12 10:58:07

In a new study, women with relatively small, HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted therapy following surgery or radiation therapy were very unlikely to have the cancer recur within a few years of treatment, investigators at Dana-Farber Cancer Institute and other research centers will report at the 2013 San Antonio Breast Cancer Symposium. The findings offer, for the first time, a set of standard treatment guidelines for...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related